Skadden is advising the underwriters in the offering. Western Copper and Gold Corporation has entered into an underwriting agreement with a syndicate of underwriters, under which the...
Western Copper and Gold Corporation’s Equity Offering
Milestone Pharmaceuticals’ $34.5 Million Common Shares Offering
Osler, Hoskin & Harcourt acted as Canadian counsel to Milestone Pharmaceuticals Inc. in the offering, Cooleyacted as US counsel to the company. Wilmer Cutler Pickering Hale...
Celldex Therapeutics’ $230.5 Million Common Stock Offering
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
Harpoon Therapeutics’ $150 Million Private Placement
Paul Hastings LLP advised TD Cowen and the placement agents in connection with Harpoon Therapeutics’ offering. Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
UroGen’s $120 Million Ordinary Shares Private Placement
Latham & Watkins represented the placement agents in the offering. UroGen Pharma Ltd. (Nasdaq: URGN) announced that it has entered into a definitive securities purchase agreement...
Savara’s $80 Million Common Stock Offering
Holland & Knight advised Savara, and Cooley advised the underwriters. Savara announced on July 13, 2023, the pricing of an underwritten offering of 21,000,000 shares of...
Verastem’s $85 Million Public Offering
Ropes & Gray advised Verastem, while Covington advised the underwriters in the offering. Verastem, Inc. announced its $85 million public offering of common stock and pre-funded warrants....
Viking Therapeutics’s $287.5 Million IPO
Mintz advised the syndicate of underwriters on the deal. Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
Staffing 360 Solutions’ $5 Million Shares Offering
Sichenzia Ross Ference represented H.C. Wainwright & Co., LLC in the offering. Staffing 360 Solutions, Inc. (NASDAQ: “STAF”) announced a $5 million public offering of securities. The...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Denali Therapeutics’ $316 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...